Vitura Health Limited has released a press release.
Psychedelic joint venture with PharmAla Biotech
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Vitura Health
- Receipt of Shareholder Notice
- S&P DJI Announces March 2023 Quarterly Rebalance
- Half Yearly Report and Accounts
- Changes to clinical operations
- Sale of one millionth unit and record revenue in November
Later from Vitura Health
- Establishment of joint venture with Releaf Group
- W.H.O. GDP certification and JV update
- Appendix 4E Preliminary Final Report
- Declaration of fully franked dividend
- Retraction of resolution
Follow Vitura Health into a list and get an email when it puts out news.
Follow Vitura Health